Search

everythinglearnresearchcommunity

for

Search:↓

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hair loss linked to higher heart disease risk in both men and women.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PRP shows potential for treating female hair loss, but more research needed.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Aromatase gene variation may increase female hair loss risk.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.